Transcatheter arterial chemoembolization of apatinib and camrelizumab (SHR1210) against liver metastasis from hepatic neuroendocrine tumor: a case report

Transcatheter arterial chemoembolization of apatinib and camrelizumab (SHR1210) against liver metastasis from hepatic neuroendocrine tumor: a case report

In this case report, we present the case of a 46-year-old woman with a hepatic neuroendocrine tumor (NET G2)-induced liver metastases. Initially, the left lateral lobectomy of the liver was performed. The post-operative pathological examination revealed NET G2, leading to the post-operative recovery...

Full description

Bibliographic Details
Main Authors: Ruobing Qi, Wenhua Yang, Sixian Zhu, Jie Mao, Bei Yang, Anhui Xu, Qiang Fu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Oncology
Subjects:
NET G2
HCC
camrelizumab (SHR1210)
apatinib
PD-1
TACE
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1278340/full

Similar Items

Similar Items